Episode 18-03 Work on the disease which affects one-third of people lead to a new drug helping patients with a very rare disease - Sjögren (“Show-gren”) -Larsson Syndrome

Published: Jan. 18, 2018, 2:37 p.m.

On this week’s Tech Nation Health, Dr. Todd Brady, CEO of Aldeyra describes their work on a disease which affects one-third of people. It led to a new drug helping patients with a very rare disease - Sjögren (“Show-gren”) -Larsson Syndrome